Souhaitez-vous accéder aux communiqués récents ?

HUDDINGE, Sweden, Aug. 28, 2003 (PRIMEZONE) -- The Board of Directors of Tripep has decided to form a new vaccine development company in the U.S. together with researchers at the Vaccine Research...

HUDDINGE, Sweden, May 20, 2003 (PRIMEZONE) -- Tripep: Payment for all shares that have been bought back will be made on May 26, 2003. Now that the final count has been completed, Tripep hereby...

HUDDINGE, Sweden, May 09, 2003 (PRIMEZONE) -- Tripep has acquired 1,353,205 of the company's own shares by way of its buy-back offer. This offer gave shareholders the right to sell one in ten of...

HUDDINGE, Sweden, May 8, 2003 (PRIMEZONE) -- As previously announced, Tripep AB (publ) has made a bid for the vaccine development company Isconova AB in Uppsala. The Board of Directors and owners of...

HUDDINGE, Sweden, May 07, 2003 (PRIMEZONE) -- Tripep AB (publ) is acquiring the vaccine development company, Isconova AB. As part of its strategy of promoting consolidation with partners in the field...

HUDDINGE, Sweden, April 30, 2003 (PRIMEZONE) -- Tripep AB (publ): -- Planned cost reductions have been implemented, resulting in a more than 50 per cent cut, without effecting R&D ...

HUDDINGE, Sweden, March 28, 2003 (PRIMEZONE) -- The Annual General Meeting of Tripep AB was held in Stockholm on 27 March, 2003. The Company's income statement and balance sheet were adopted and...

HUDDINGE, Sweden, Feb. 27, 2003 (PRIMEZONE) -- The Annual General Meeting of Tripep AB (Stocholm:TPEP) will be held on March 27, 2003 at 6 p.m. at the Berns Conference Hall, Rektangelsalen at...

HUDDINGE, Sweden, Feb. 27, 2003 (PRIMEZONE) -- The shareholders of Tripep AB (publ) (Stockholm:TPEP) are hereby notified that the Annual General Meeting of Tripep will be held on Thursday, March 27,...

HUDDINGE, Sweden, Jan. 31, 2003 (PRIMEZONE) -- Tripep AB (publ): -- A new Board of Directors was elected at the extraordinary meeting of shareholders held on September 17, 2002. The new...